Sai Parenterals Ltd

NSE: SAIPARENT · BSE: 544742 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹521.65
Market cap: ₹2,305 Cr
Revenue (annual): ₹381.0 Cr
Net profit (annual): ₹14.26 Cr
P/E (TTM): 111.0×Sector 47.3×
Promoter holding: 51.16%+0.00% QoQ
FII holding: 4.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Earnings Call 4 New Order Win 3 Financial Results 3 Board Meeting Outcome 3 Results Update 2 Merger & Restructuring 2 Management Change 2 Fund Raise 2 Board Meeting Date 2 Annual General Meeting 2 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

6 Jul 2026 15:17 IST BSE

Board Meeting Outcome

Sai Parenterals Board Meeting Outcome

Sai Parenterals Ltd announced the appointment of secretarial, internal and cost auditors, and authorised the MD to explore growth opportunities. The board met on 06 July 2026.

Read the filing ↗

20 Apr 2026 14:49 IST BSE

Board Meeting Outcome

Sai Parenterals Board Meeting Outcome

Sai Parenterals Ltd's board approved an unsecured loan of approximately ₹11.91 Crore (AUD 1.75 million) to its wholly-owned subsidiary, Sai Singapore Pte. Ltd. The funds will be used for downstream investment in Noumed Pharmaceuticals Pty Limited, Australia, which is a step-down subsidiary of the company.

Value: ₹11.91 Cr

Read the filing ↗

14 Apr 2026 20:24 IST BSE

Board Meeting Outcome

Sai Parenterals Board Meeting Outcome

Sai Parenterals Ltd has scheduled a Board Meeting on April 20, 2026, to consider a proposal for investing in or lending to its step-down Australian subsidiary, Noumed Pharmaceuticals Pty Limited. The transaction would be executed through its wholly owned subsidiary Sai Parenterals PTE Limited.

Read the filing ↗